Backing a lower-cost oxygen carrier for bioprocessing.
Synfera is an early-stage synthetic biology company in Calgary, Alberta, commercializing an engineered oxygen-carrying protein for cell culture and adjacent markets.
Founded by an award-winning international competition team
Teams competed; Synfera's project earned a gold medal
In preparation, with pilot partners being onboarded
Targeted price advantage over market alternatives
Why Synfera, and why now.
A platform protein, not a single product
The same engineered oxygen carrier applies across cell culture, tissue engineering and preservation, and bioreactor processes, markets that share one bottleneck: oxygen.
Cost structure as a moat
At the working concentration for cell culture, our target price sits more than 25% below current alternatives without trading away effectiveness.
Recognised technical origin
Synfera was founded out of a team whose project won a gold medal, the Best Safety and Security Award, and a Best Entrepreneurship nomination.
Stage of development.
Engineered oxygen carrier based on a natural macromolecule
In-house data generation on proliferation and productivity
Product form and storage specification for cell culture
Early partners piloting in cell culture applications
Recent recognition
Synfera featured in the Connect2Innovate team showcase
Read on Connect2Innovate →First Runner-up at the 2025 iGEM Startup Showcase
Read on iGEM Innovation (LinkedIn) →Can earthworms bring relief to a global blood donor shortage?
Read on University of Calgary News →Investor and partnership inquiries.
Reach the Synfera team directly at business@synfera.ca to request materials or arrange a conversation.